Tau protein is a potential biological marker for normal pressure hydrocephalus

Psychiatry and Clinical Neurosciences

Volumn 54, Issue 2, 2000, Pages 199-202

  Kudo, Takashi ^a,c   Mima, Tatsuo ^b   Hashimoto, Ryouta ^a   Nakao, Kazuhisa ^a   Morihara, Takashi ^a   Tanimukai, Hitoshi ^a   Tsujio, Ichiro ^a   Koike, Yuko ^a   Tagami, Shinji ^a   Mori, Hiroshi ^a   Nakamura, Yu ^d   Tanaka, Toshihisa ^d   Mori, Koreaki ^b   Takeda, Masatoshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NONE

Author keywords

Alzheimer's disease; Biological marker; Cerebrospinal fluid; Neurodegeneration; Normal pressure hydrocephalus; Tau

Indexed keywords

BIOCHEMICAL MARKER; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID PRESSURE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYDROCEPHALUS; INTRACRANIAL PRESSURE; MALE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; PROTEIN PHOSPHORYLATION; SHUNTING; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; DEMENTIA; FEMALE; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TAU PROTEINS;

EID: 12944260699     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1819.2000.00658.x     Document Type: Article

References (11)

1. Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. Symptomatic occult hydrocephalus with 'normal' cerebrospinal fluid pressure. A treatable syndrome. N. Engl. J. Med. 1965; 273: 117-126.
2. Hakim S, Adams RD. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid pressure. J. Neurol. Sci. 1965; 2: 307-327.
3. Benson DF, LeMay M, Patten DH. Rubens A. Diagnosis of normal pressure hydrocephalus. N. Engl. J. Med. 1970; 283: 609-615.
4. Ojemann RG. Normal pressure hydrocephalus. Clin. Neurosurg. 1971; 18: 337-370.
5. Mori H, Hosoda K, Matsubara E et al. Tau in cerebrospinal fluid: Establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau. Neurosci. Lett. 1995; 186: 181-183.
6. Vandermeeren M, Mercken M, Vanmechelen E et al. Detection of protein in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J. Neurochem. 1993; 61: 1828-1834.
7. Arai H, Morikawa Y, Higuchi M et al. Cerebrospinal fluid tau level in neurodegenerative diseases with distinct tau-related pathology. Biochem. Biophys. Res. Commun. 1997; 236: 262-264.
8. Otto M, Wiltfang J, Tunami H et al. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci. Lett. 1997; 225: 210-212.
9. Morihara T, Kudo T, Ikura Y et al. Increased tau protein level in postmortem cerebrospinal fluid. Psychiatr. Clin. Neurosci. 1998; 52: 107-110.
10. El Gammal TE, Allen MB, Brooks BS, Mark EK. MR evaluation of hydrocephalus. Am. J. Neurosci. Res. 1987; 8: 591-597.
11. Jack CR, Mokri B, Laws ER, Houser OW, Baker HL, Petersen RC. MR findings in normal-pressure hydrocephalus: Significance and comparison with other forms of dementia. J. Comput. Assist. Tomogr. 1987; 11: 923-931.